COVID-19 and autism

The current pandemic of Covid-19 has created a paradigm for possibly gaining greater insight in two conditions: 1).. Inflammatory maladies in pregnancy, and. 2).. The biology of IGF-1 in autism. Studies since the beginning of this century have supported the view that IGF-1 deficiency in the neonate...

Descripción completa

Detalles Bibliográficos
Autor principal: Steinman, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252020/
https://www.ncbi.nlm.nih.gov/pubmed/32416411
http://dx.doi.org/10.1016/j.mehy.2020.109797
Descripción
Sumario:The current pandemic of Covid-19 has created a paradigm for possibly gaining greater insight in two conditions: 1).. Inflammatory maladies in pregnancy, and. 2).. The biology of IGF-1 in autism. Studies since the beginning of this century have supported the view that IGF-1 deficiency in the neonate defines the basis of autism. As a result, it appears that interleukin-6 in corona virus-based infections causes reduced defenses because of suppressed IGF-1, especially in older patients. This may also portend an increase of autism in the offspring of gravidas currently affected severely by Covid-19.

Ejemplares similares